Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment

Patient-derived xenograft models (PDX) have been extensively used to study the molecular and clinical features of cancers. Here the authors present a cohort of 536 PDX models from 25 cancers, as well as their genomic and evolutionary profiles and their suitability for clinical trials.

Guardado en:
Detalles Bibliográficos
Autores principales: Hua Sun, Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl, Sherri R. Davies, Matthew H. Bailey, Tina M. Primeau, Jeremy Hoog, Jacqueline L. Mudd, Dennis A. Dean, Rajesh Patidar, Li Chen, Matthew A. Wyczalkowski, Reyka G. Jayasinghe, Fernanda Martins Rodrigues, Nadezhda V. Terekhanova, Yize Li, Kian-Huat Lim, Andrea Wang-Gillam, Brian A. Van Tine, Cynthia X. Ma, Rebecca Aft, Katherine C. Fuh, Julie K. Schwarz, Jose P. Zevallos, Sidharth V. Puram, John F. Dipersio, The NCI PDXNet Consortium, Brandi Davis-Dusenbery, Matthew J. Ellis, Michael T. Lewis, Michael A. Davies, Meenhard Herlyn, Bingliang Fang, Jack A. Roth, Alana L. Welm, Bryan E. Welm, Funda Meric-Bernstam, Feng Chen, Ryan C. Fields, Shunqiang Li, Ramaswamy Govindan, James H. Doroshow, Jeffrey A. Moscow, Yvonne A. Evrard, Jeffrey H. Chuang, Benjamin J. Raphael, Li Ding
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/e6286532f9bc487a87943a142621d7a3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e6286532f9bc487a87943a142621d7a3
record_format dspace
spelling oai:doaj.org-article:e6286532f9bc487a87943a142621d7a32021-12-02T16:35:07ZComprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment10.1038/s41467-021-25177-32041-1723https://doaj.org/article/e6286532f9bc487a87943a142621d7a32021-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25177-3https://doaj.org/toc/2041-1723Patient-derived xenograft models (PDX) have been extensively used to study the molecular and clinical features of cancers. Here the authors present a cohort of 536 PDX models from 25 cancers, as well as their genomic and evolutionary profiles and their suitability for clinical trials.Hua SunSong CaoR. Jay MashlChia-Kuei MoSimone ZaccariaMichael C. WendlSherri R. DaviesMatthew H. BaileyTina M. PrimeauJeremy HoogJacqueline L. MuddDennis A. DeanRajesh PatidarLi ChenMatthew A. WyczalkowskiReyka G. JayasingheFernanda Martins RodriguesNadezhda V. TerekhanovaYize LiKian-Huat LimAndrea Wang-GillamBrian A. Van TineCynthia X. MaRebecca AftKatherine C. FuhJulie K. SchwarzJose P. ZevallosSidharth V. PuramJohn F. DipersioThe NCI PDXNet ConsortiumBrandi Davis-DusenberyMatthew J. EllisMichael T. LewisMichael A. DaviesMeenhard HerlynBingliang FangJack A. RothAlana L. WelmBryan E. WelmFunda Meric-BernstamFeng ChenRyan C. FieldsShunqiang LiRamaswamy GovindanJames H. DoroshowJeffrey A. MoscowYvonne A. EvrardJeffrey H. ChuangBenjamin J. RaphaelLi DingNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-20 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Hua Sun
Song Cao
R. Jay Mashl
Chia-Kuei Mo
Simone Zaccaria
Michael C. Wendl
Sherri R. Davies
Matthew H. Bailey
Tina M. Primeau
Jeremy Hoog
Jacqueline L. Mudd
Dennis A. Dean
Rajesh Patidar
Li Chen
Matthew A. Wyczalkowski
Reyka G. Jayasinghe
Fernanda Martins Rodrigues
Nadezhda V. Terekhanova
Yize Li
Kian-Huat Lim
Andrea Wang-Gillam
Brian A. Van Tine
Cynthia X. Ma
Rebecca Aft
Katherine C. Fuh
Julie K. Schwarz
Jose P. Zevallos
Sidharth V. Puram
John F. Dipersio
The NCI PDXNet Consortium
Brandi Davis-Dusenbery
Matthew J. Ellis
Michael T. Lewis
Michael A. Davies
Meenhard Herlyn
Bingliang Fang
Jack A. Roth
Alana L. Welm
Bryan E. Welm
Funda Meric-Bernstam
Feng Chen
Ryan C. Fields
Shunqiang Li
Ramaswamy Govindan
James H. Doroshow
Jeffrey A. Moscow
Yvonne A. Evrard
Jeffrey H. Chuang
Benjamin J. Raphael
Li Ding
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment
description Patient-derived xenograft models (PDX) have been extensively used to study the molecular and clinical features of cancers. Here the authors present a cohort of 536 PDX models from 25 cancers, as well as their genomic and evolutionary profiles and their suitability for clinical trials.
format article
author Hua Sun
Song Cao
R. Jay Mashl
Chia-Kuei Mo
Simone Zaccaria
Michael C. Wendl
Sherri R. Davies
Matthew H. Bailey
Tina M. Primeau
Jeremy Hoog
Jacqueline L. Mudd
Dennis A. Dean
Rajesh Patidar
Li Chen
Matthew A. Wyczalkowski
Reyka G. Jayasinghe
Fernanda Martins Rodrigues
Nadezhda V. Terekhanova
Yize Li
Kian-Huat Lim
Andrea Wang-Gillam
Brian A. Van Tine
Cynthia X. Ma
Rebecca Aft
Katherine C. Fuh
Julie K. Schwarz
Jose P. Zevallos
Sidharth V. Puram
John F. Dipersio
The NCI PDXNet Consortium
Brandi Davis-Dusenbery
Matthew J. Ellis
Michael T. Lewis
Michael A. Davies
Meenhard Herlyn
Bingliang Fang
Jack A. Roth
Alana L. Welm
Bryan E. Welm
Funda Meric-Bernstam
Feng Chen
Ryan C. Fields
Shunqiang Li
Ramaswamy Govindan
James H. Doroshow
Jeffrey A. Moscow
Yvonne A. Evrard
Jeffrey H. Chuang
Benjamin J. Raphael
Li Ding
author_facet Hua Sun
Song Cao
R. Jay Mashl
Chia-Kuei Mo
Simone Zaccaria
Michael C. Wendl
Sherri R. Davies
Matthew H. Bailey
Tina M. Primeau
Jeremy Hoog
Jacqueline L. Mudd
Dennis A. Dean
Rajesh Patidar
Li Chen
Matthew A. Wyczalkowski
Reyka G. Jayasinghe
Fernanda Martins Rodrigues
Nadezhda V. Terekhanova
Yize Li
Kian-Huat Lim
Andrea Wang-Gillam
Brian A. Van Tine
Cynthia X. Ma
Rebecca Aft
Katherine C. Fuh
Julie K. Schwarz
Jose P. Zevallos
Sidharth V. Puram
John F. Dipersio
The NCI PDXNet Consortium
Brandi Davis-Dusenbery
Matthew J. Ellis
Michael T. Lewis
Michael A. Davies
Meenhard Herlyn
Bingliang Fang
Jack A. Roth
Alana L. Welm
Bryan E. Welm
Funda Meric-Bernstam
Feng Chen
Ryan C. Fields
Shunqiang Li
Ramaswamy Govindan
James H. Doroshow
Jeffrey A. Moscow
Yvonne A. Evrard
Jeffrey H. Chuang
Benjamin J. Raphael
Li Ding
author_sort Hua Sun
title Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment
title_short Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment
title_full Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment
title_fullStr Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment
title_full_unstemmed Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment
title_sort comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/e6286532f9bc487a87943a142621d7a3
work_keys_str_mv AT huasun comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT songcao comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT rjaymashl comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT chiakueimo comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT simonezaccaria comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT michaelcwendl comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT sherrirdavies comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT matthewhbailey comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT tinamprimeau comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT jeremyhoog comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT jacquelinelmudd comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT dennisadean comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT rajeshpatidar comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT lichen comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT matthewawyczalkowski comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT reykagjayasinghe comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT fernandamartinsrodrigues comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT nadezhdavterekhanova comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT yizeli comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT kianhuatlim comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT andreawanggillam comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT brianavantine comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT cynthiaxma comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT rebeccaaft comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT katherinecfuh comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT juliekschwarz comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT josepzevallos comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT sidharthvpuram comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT johnfdipersio comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT thencipdxnetconsortium comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT brandidavisdusenbery comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT matthewjellis comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT michaeltlewis comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT michaeladavies comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT meenhardherlyn comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT bingliangfang comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT jackaroth comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT alanalwelm comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT bryanewelm comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT fundamericbernstam comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT fengchen comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT ryancfields comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT shunqiangli comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT ramaswamygovindan comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT jameshdoroshow comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT jeffreyamoscow comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT yvonneaevrard comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT jeffreyhchuang comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT benjaminjraphael comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
AT liding comprehensivecharacterizationof536patientderivedxenograftmodelsprioritizescandidatesfortargetedtreatment
_version_ 1718383785131638784